ACGN
Aceragen Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. idera is focused on harnessing the potential of our proprietary technology to treat genetically defined forms of b-cell lymphomas and rare autoimmune diseases.
Market Cap: 3.71 Million
Primary Exchange: NASDAQ
Website: http://www.iderapharma.com/
Shares Outstanding: 8.42 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.07050200747676548
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 161 trading days
From: 2023-01-18 To: 2023-08-21
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|